Was Coronavirus A Factor In Cipla's Albuterol FDA Approval?
Indian Firm Was Recently Given Nod For First US Proventil Rival
Executive Summary
The agency said Cipla’s ANDA met all the requirements for approval, but also that there is increased demand for the products.
You may also be interested in...
FDA Expedites ANDA Postapproval Manufacturing Changes
Generic drugs program has approved almost 300 manufacturing changes to help shore up the supply chain, with some prior approval supplements being downgraded to ‘changes being effected’ supplements, FDA officials said at GDUFA III kick-off meeting.
Cipla Propels 'Lung Leadership' Plans
Cipla’s fourth-quarter 2020 sales were hit because of COVID-19- related dispatch challenges, though it remains upbeat about the prospects of interchangeable albuterol and the latest filing for generic Advair Diskus as part of its quest for lung leadership.
Cipla Propels Lung Leadership Plans, Reimagines Operating Models
Cipla’s fourth-quarter 2020 sales were hit because of COVID-19- related dispatch challenges, though it remains upbeat about the prospects of interchangeable albuterol and the latest filing for generic Advair Diskus as part of its quest for lung leadership.